Ancona Margaret bought MYGN
February 7, 2025 · Form 4 insider transaction
Ancona Margaret bought 6,468 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 25 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,468
Price
$0.00
Total value
N/A
InsiderAncona Margaret
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2025
Filing dateMarch 4, 2025
Shares owned after82,171
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025.